Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Only 30% of adults in the United States have been vaccinated against hepatitis B.
Nearly 70% of prior HBV vaccine nonresponders produced adequate antibodies after successful HCV treatment.
Authors emphasize the need for increased hepatitis B vaccine awareness and education.
Testing is a fundamental step toward treating hepatitis C, yet many Latino Americans are not being screened.
Vaccines are tested for safety, but like all medical products, they can sometimes cause side effects.
Conspiracy theorists ignore Magic Johnson’s own words: “I am certain that I was infected by having unprotected sex with a woman.”
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
Even without HBV immunoglobulin, no infants acquired hepatitis B from mothers with a high viral load.
Nearly all HIV-positive study participants achieved protective antibody levels after two doses of Heplisav-B.
People with HIV are at greater risk for hepatitis B but are less likely to get vaccinated and respond to vaccines.
Millions of Americans are living with viral hepatitis. #HepTestingDay urges you to find out whether you’re one of them.
Only 30% of U.S. adults have been vaccinated against the liver disease. Here’s how the Hepatitis B Foundation aims to change that.
The PreHevbrio vaccine produces higher antibody levels and offers faster protection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.